# Quebec SEAO #JD-AAI-20261001; SEAO 20174220

Request for Information: 16F Aspiration Catheter for Thrombectomy

**Posted:** October 01, 2026
**Respond By:** October 15, 2026
**Identifier:** JD-AAI-20261001; SEAO 20174220
**NAICS:** 423490, 339112

Santé Québec Laurentides is seeking supplier information on a large-bore aspiration catheter for thrombectomy procedures.
- **Government buyer:** Santé Québec Laurentides; the angioradiology department is the intended user.
- **OEM:** **Penumbra** is the manufacturer of the reference product. No resellers or other vendors are named.
- **Requested product:** Penumbra Lightning Flash Indigo System 16F aspiration catheter, part number **LITNGFHT1100H1**; quantity is not stated.
  - Intended for thrombectomy, including emergency use; approximately 16F diameter and 100 cm long.
  - Include all accessories needed for use. An equivalent or superior product may be proposed.
- **Key requirements:** The proposed product must meet or exceed the reference product’s performance, safety, and quality; work with Santé Québec Laurentides’ existing aspiration pump, cart, and other equipment; and be approved for use in Canada.
- **Supplier information requested:** Detailed product description, technical sheet identifying the manufacturer and catalogue number, and documentation supporting equivalency. Acceptance depends on a compatibility and clinical suitability trial; samples must be provided at no cost if requested.

### Description

Santé Québec Laurentides is seeking information from suppliers able to provide the Penumbra Lightning Flash Indigo System 16F aspiration catheter, or an equivalent or superior product, for thrombectomy procedures in its angioradiology department. The product must be approximately 16F and 100 cm long, include the required accessories, meet the reference product’s performance, safety, and quality standards, and be compatible with the agency’s existing equipment. Interested suppliers must submit a detailed product description, technical sheet, equivalency documentation, and proof of approval for use in Canada by email by October 15, 2026, at 4:00 p.m. Quebec Legal Time. Product acceptance is conditional on a prior compatibility and clinical suitability trial; samples must be provided at no cost if requested.

[View original listing](https://seao.gouv.qc.ca/avis-resultat-recherche/consulter?ItemId=3aadbad3-5397-4873-9248-84938863bf1b)